Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
The University of Texas MD Anderson Cancer Center · The University of Texas Health Science Center at Houston · +1 more institution
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
2,162
total citations
- FWCI
- 30.07
- Percentile
- 100%
- References
- 184
Citations per year
Authors
5- BTBryan T. HennessyCorresponding
The University of Texas MD Anderson Cancer Center
- DLDebra L. Smith
The University of Texas Health Science Center at Houston, The University of Texas MD Anderson Cancer Center
- PTPrahlad T. Ram
Center for Systems Biology, The University of Texas MD Anderson Cancer Center
- YLYiling Lu
The University of Texas MD Anderson Cancer Center, Center for Systems Biology
- GBGordon B. Mills
The University of Texas MD Anderson Cancer Center, Center for Systems Biology
Topics & keywords
Topics
Keywords
- PI3K/AKT/mTOR pathway
- Drug discovery
- Protein kinase B
- Chromosomal translocation
- Cancer research
- Targeted therapy
- Cancer
- Phosphatidylinositol
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.